SCHEMBL2586662

SCHEMBL2586662

CC(=O)C(Cc1ccc(O)c(O)c1)C(N)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 7/20 0.58
KDM4E B2RXH2 6/20 0.58
HSD17B10 Q99714 6/20 0.58
HIF1A Q16665 5/20 0.58
RECQL P46063 4/20 0.58
TDP1 Q9NUW8 4/20 0.58
USP2 O75604 3/20 0.58
PTGS2 P35354 3/20 0.58
EGFR P00533 3/20 0.58
ADORA3 P0DMS8 2/20 0.58
HTR2A P28223 2/20 0.58
PTGS1 P23219 2/20 0.58
FYN P06241 2/20 0.58
SLC7A5 Q01650 2/20 0.58
LCK P06239 1/20 0.58
ALOX12 P18054 5/20 0.53
HPGD P15428 5/20 0.53
ALDH1A1 P00352 4/20 0.53
BLM P54132 4/20 0.53
MAPT P10636 4/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28036283 0.86 KDM4E (0.67) ALOX15KDM4EHSD17B10HIF1ARECQL
SCHEMBL12137123 0.81 ALOX15 (0.74) ALOX15KDM4EHSD17B10HIF1ARECQL
SCHEMBL19565599 0.81 ALOX15 (0.74) ALOX15KDM4EHSD17B10HIF1ARECQL
SCHEMBL21729924 0.81 ALOX15 (0.74) ALOX15KDM4EHSD17B10HIF1ARECQL
SCHEMBL1069483 0.81 ALOX15 (0.74) ALOX15KDM4EHSD17B10HIF1ARECQL
SCHEMBL13661903 0.81 ALOX15 (0.74) ALOX15KDM4EHSD17B10HIF1ARECQL
SCHEMBL10029410 0.81 ALOX15 (0.74) ALOX15KDM4EHSD17B10HIF1ARECQL
SCHEMBL20765409 0.81 ALOX15 (0.74) ALOX15KDM4EHSD17B10HIF1ARECQL
Hydrochloric Acid SCHEMBL20765475 0.79 ALOX15 (0.72) ALOX15KDM4EHSD17B10HIF1ARECQL
Hydrochloric Acid SCHEMBL20764445 0.79 ALOX15 (0.72) ALOX15KDM4EHSD17B10HIF1ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8048926-B2 L-DOPA amide derivatives and uses thereof YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2011-11-01 US disclosed
EP-1596808-A4 L-DOPA AMIDE DERIVATIVES AND USES THEREOF YISSUM RES DEV CO (IL) 2007-04-04 EP disclosed
US-20060025385-A1 L-DOPA amide derivatives and uses thereof YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2006-02-02 US disclosed
EP-1596808-A2 L-DOPA AMIDE DERIVATIVES AND USES THEREOF YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2005-11-23 EP disclosed
WO-2004069146-A2 L-DOPA AMIDE DERIVATIVES AND USES THEREOF YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2004-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025385-A1 L-DOPA amide derivatives and uses thereof SNCA, DBH, PARK7 ALOX15 1467/4885KDM4E 3395/4885HSD17B10 2592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.